The American College of Chest Physicians’ “Therapy for Pulmonary Arterial Hypertension in Adults” was updated in March 2019. According to the new recommendations, which of the following treatments is recommended to improve the 6-minute walk distance of treatment-naïve patients with pulmonary arterial hypertension (PAH) who are functional class II or III based on World Health Organization (WHO) standards?
Better luck next time
The guideline also recommends that stable or symptomatic patients with PAH taking background therapy with ambrisentan should add tadalafil to their treatment regimen to improve the 6-minute walk distance.
For more PAH content, visit the Resource Center.
Nice job!